20 states accuse American Medical Association of selective science on youth gender transitions https://t.co/YuNbnNaxU5 pic.twitter.com/DbrbLJ7Tom
— New York Post (@nypost) February 24, 2026
A coalition of 20 attorneys general are putting pressure on the American Medical Association to explain its support for puberty blockers for children, calling the group’s position inconsistent with the evidence after it recently came out against gender-related surgeries for children.
In a letter penned by Alabama Attorney General Steve Marshall on behalf of the coalition and sent to AMA CEO Dr. John J. Whyte on Tuesday, the group praised the AMA for agreeing with the American Society of Plastic Surgeons that gender-related surgeries should be deferred to adulthood due to a lack of “clear evidence” to support the interventions.
But the group argued the evidence is similarly weak for puberty blockers and cross-sex hormones used to treat gender dysphoria in children.
“We thus find it concerning that the AMA continues to support the use of puberty blockers and cross-sex hormones to treat gender dysphoria in minors,” the letter states. “The quality of evidence is the same as it is for surgeries: low and very-low quality.”